These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 16940181)

  • 21. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
    Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
    Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.
    Xiang Y; Lu DL; Li JP; Yu CX; Zheng DL; Huang X; Wang ZY; Hu P; Liao XH; Zhang TC
    IUBMB Life; 2016 Jun; 68(6):477-87. PubMed ID: 27156566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
    Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS
    Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.
    Frietze S; Lupien M; Silver PA; Brown M
    Cancer Res; 2008 Jan; 68(1):301-6. PubMed ID: 18172323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression.
    Huang ZM; Ge HF; Yang CC; Cai Y; Chen Z; Tian WZ; Tao JL
    Kaohsiung J Med Sci; 2019 Aug; 35(8):467-473. PubMed ID: 31063232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
    Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
    Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
    Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
    Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.
    Chen H; Yu C; Shen L; Wu Y; Wu D; Wang Z; Song G; Chen L; Hong Y
    Pathol Res Pract; 2020 Dec; 216(12):153236. PubMed ID: 33038688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.
    Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J
    Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
    Anzick SL; Kononen J; Walker RL; Azorsa DO; Tanner MM; Guan XY; Sauter G; Kallioniemi OP; Trent JM; Meltzer PS
    Science; 1997 Aug; 277(5328):965-8. PubMed ID: 9252329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer.
    Reiter R; Wellstein A; Riegel AT
    J Biol Chem; 2001 Oct; 276(43):39736-41. PubMed ID: 11502741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
    Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
    Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone morphogenetic protein 4 regulates microRNA expression in breast cancer cell lines in diverse fashion.
    Alarmo EL; Havunen R; Häyrynen S; Penkki S; Ketolainen J; Nykter M; Kallioniemi A
    Genes Chromosomes Cancer; 2016 Mar; 55(3):227-36. PubMed ID: 26684238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.
    Oh A; List HJ; Reiter R; Mani A; Zhang Y; Gehan E; Wellstein A; Riegel AT
    Cancer Res; 2004 Nov; 64(22):8299-308. PubMed ID: 15548698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
    Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells.
    Xiao X; Tang C; Xiao S; Fu C; Yu P
    Oncol Res; 2013; 20(11):537-44. PubMed ID: 24063284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance.
    De Cola A; Volpe S; Budani MC; Ferracin M; Lattanzio R; Turdo A; D'Agostino D; Capone E; Stassi G; Todaro M; Di Ilio C; Sala G; Piantelli M; Negrini M; Veronese A; De Laurenzi V
    Cell Death Dis; 2015 Jul; 6(7):e1823. PubMed ID: 26181203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.